3 ms·
The early research is done on federal grants. What costs real money is late-stage development and especially clinical research, startups and universities are no
by HarryHirsch 7y ago
The early research is done on federal grants. What costs real money is late-stage development and especially clinical research, startups and universities are not at all equipped for that.
The financing model is problematic. Return on investment is much higher and faster in IT, besides there is a mismatch between what the market favours and where future clinical needs are (the antibiotic crisis, neglected tropical diseases).
- claudeganon 7y agoIsn’t the solution then to build a national infrastructure for late stage trials as opposed to putting life-saving drugs behind a ludicrous paywall, whose price is determined by the opaque malfeasance of the healthcare system in the US?
- deleted 7y ago[deleted]
- lmm 7y agoLate-stage trials are enormously costly and negative results are common. To publicly fund them, we'd have to be ok with governments spending billions and getting nothing for it. And after the fact there'd be a long line of people saying how $treatment was obviously never going to work and only an idiot would ever have let it go forward for stage 3 trials. I'm not opposed to the idea, but I think you'd struggle to make it politically achievable.